Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-005996
Filing Date
2024-10-25
Accepted
2024-10-25 10:15:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 p24-3020sc13g.htm SC 13G 50170
  Complete submission text file 0000902664-24-005996.txt   51944
Mailing Address 277 PARK AVE 23RD FLOOR NEW YORK NY 10172
Business Address 277 PARK AVE 23RD FLOOR NEW YORK NY 10172 2122872500
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000919185 (see all company filings)

EIN.: 134131516 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Subject) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90859 | Film No.: 241395193
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)